NCT03719105 2025-08-08Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/LymphomaNew York Medical CollegePhase EARLY_PHASE1 Recruiting40 enrolled
NCT05313243 2025-03-20Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell LymphomaYale UniversityPhase 2 Recruiting32 enrolled